Wird geladen...
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
Glioblastoma (GBM) is a deadly and debilitating brain tumor with an abysmal prognosis. The standard therapy for GBM is surgery followed by radiation and chemotherapy with temozolomide (TMZ). Treatment of GBMs remains a challenge, largely due to the fast degradation of TMZ, inability to deliver an ef...
Gespeichert in:
| Veröffentlicht in: | ACS Appl Mater Interfaces |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4637162/ https://ncbi.nlm.nih.gov/pubmed/25751368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/am5092165 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|